## **Core Concept**
The treatment of acute depression involves the use of pharmacotherapy, psychotherapy, or a combination of both. The primary goal is to alleviate symptoms and improve quality of life. **Selective serotonin reuptake inhibitors (SSRIs)** are commonly used as first-line treatment due to their efficacy and relatively favorable side effect profile.

## **Why the Correct Answer is Right**
SSRIs are considered the first-line treatment for acute depression because they effectively increase the levels of serotonin in the brain, which helps to improve mood and reduce symptoms of depression. They have a relatively favorable side effect profile compared to other antidepressants like tricyclic antidepressants (TCAs) and monoamine oxidase inhibitors (MAOIs). Examples of SSRIs include **fluoxetine**, **sertraline**, and **paroxetine**.

## **Why Each Wrong Option is Incorrect**
* **Option A:** While **Tricyclic Antidepressants (TCAs)** can be effective for treating depression, they are not typically used as first-line treatment due to their side effects, such as anticholinergic effects, and the availability of safer alternatives like SSRIs.
* **Option B:** **Monoamine Oxidase Inhibitors (MAOIs)** are another class of antidepressants but are not usually the first choice for acute depression due to dietary restrictions (avoiding tyramine-containing foods to prevent hypertensive crisis) and interactions with other medications.
* **Option D:** **Psychotherapy** alone can be effective for mild to moderate depression but is often used in conjunction with pharmacotherapy for more severe cases or when a quicker response is needed.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that SSRIs are generally considered first-line for the treatment of acute depression due to their efficacy and safety profile. However, the choice of antidepressant can depend on individual patient factors, including side effect profiles, potential drug interactions, and previous response to medications.

## **Correct Answer:** . SSRIs